Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Reduction of Myocardial Damage During Angiography (ARMYDA-IMR)
NCT01761656Phase 2Unknown
- Sponsor
- Central South University
- Start
- Dec 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in stable angina, unstable angina, non-ST segment elevation myocardial infarction (NSTEMI), sponsored by Central South University. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
stable anginaunstable anginanon-ST segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT01761656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01761656.